The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

The FDA approved treosulfan (Grafapex) with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell ...

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.

Today, the FDA issued a warning about the risk of anaphylaxis, a rare but life-threatening allergic reaction, linked to ...

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

W ith respiratory-disease season in full swing and a bird flu outbreak rapidly evolving, the new Trump Administration has ordered federal health agencies to secure White House approval before ...

After the Supreme Court overturned Roe in 2022, anti-abortion advocates launched a barrage of litigation, including a federal ...

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

A New York aesthetician was arrested on Wednesday for allegedly buying counterfeit Botox from China and injecting it into ...

During his presentation at the J.P. Morgan Healthcare Conference last week, Incyte CEO Hervé Hoppenot took investors on a ...